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ABSTRACT 
Vulvovaginal candidiasis (VVC) is the second normal of vaginal mucosal infection after bacterial that influencing 
right around 70%-75% of women once in a lifetime. Azoles antibiotics are used in treatment for VVC but limited 
because cause drug resistance in patients. Therefore, today need for new antifungal agents for Candida albicans 
infection that safe and without side effect. This article reviews Indonesian medicinal plants related to the antifungal 
activity and mechanisms of action against C. albicans. The searches for this review were conducted via the databases 
PubMed, Google Scholar, online Science Direct, Science and Technology Index. The document relevant analyzed and 
included in the study. Almost 34 medicinal plants used for anti-Candida in Indonesia were reported. About 5.88% and 
94.12% of Indonesian medicinal plants were significant and weak as an anti-Candida activity, respectively. The plants 
with the greatest anti-Candida activity were Curcuma xanthorrhiza and Syzygium aromaticum. The anti-Candida 
action involved disruption of hyphae production, membrane permeabilization, cell wall, biofilm formation, envelope, 
and filament formation. These results contribute to the drug discovering of the anti-Candida from Indonesian 
medicinal plants. 
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INTRODUCTION 
Vulvovaginal candidiasis (VVC) is an infection of the vagina caused by Candida spesies1 and diagnosed 
with clinical manifestations of hyperemia, pruritus, vaginal discomfort, leucorrhea, burning, soreness, 
dyspareunia, vaginal and vulvar erythema.2 VVC is the second most common cause vaginosis in mucosal 
or vaginal after bacterial infections. Approximately, 70-75% of women reported to have suffered at least 
one episode of VVC during their life and about 40%-50% of these women experienced recurrent type, with 
4 or more episodes within one year. In Indonesia, it constitutes 11.2-28.9% of all cases of vaginosis which 
prevalence in women with high-risk factors.3 The antibiotics, particularly azoles drugs type, are used in 
treatment for VVC.4 But in the treatment of Candida albicans infection, azoles antibiotics are limited 
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because has led to the development of drug resistance in patients.5, 6 Currently, according to the literature, 
many researchers are focused on finding plant-derived medicines7-9 and related bioactive due to efficacy 
effects for anti-Candida10-12 because medicinal plants had been reported to be safe and without side effect.13-
15 Indonesia, a country in southeast Asia, has a diverse flora that potential as medicinal plants for anti-
Candida applications. The present review reports the Indonesian medicinal plants to be efficient against C. 
albicans by carrying out their anti-Candida activity and their mechanism of action.  
This review was carried out using systematic literature search on the Indonesian medicinal plants in the 
databases PubMed, Google Scholar, online ScienceDirect, Science and Technology Index, and Portal 
Garuda. Articles published up to the end of July 2017 were used for the review with some inclusion and 
exclusion criteria. The language articles published were not considered. The search keywords included 
“Candida albicans”, “Candida albicans and drug effects”, “Candidiasis and therapy”, “antifungal activities 
of plants”, “anti-candida albicans activity of plants”, “Candida and natural products”, and “medicinal plants 
as sources of antifungals”. Medicinal plants are selected based on information from data of Indonesian 
National Agency for Drug and Food Control (BPOM), Republic of Indonesia. 
 
Anti-Candida of Indonesian Medicinal Plants 
Currently, there were used five types antifungals for fungal infection included azoles, polyenes, 
echinocandins, allylamines, and fluoropyrimidines16. But there are limited in the application of these 
antifungal for C. albicans infection that has led to increasing drug resistance and toxicity in patients17, 18. 
The medicinal plants are shown to have safety and efficacy in pharmacological activities including as 
antifungal activity19, 20; it potential for developing new antifungal in tackling Candida infection.  
Traditionally, Indonesian medicinal plants have been used by the humans for antifungal activities such as 
anti-Candida21. A summary of the medicinal plants used to treat C. albicans in Indonesia is presented in 
Table 1. From this table are enumerated of describing plant species and family, plant parts used, type of 
products, information of the main compounds or group of compounds, if any, test system and concentration 
or dose (MIC and MFC) used, and references. 
 
Table-1: List of Indonesian medicinal plants with anti-Candida activity and its secondary metabolite compounds 
 
Plant/Family Local name Part(s) Product(s) Major 
compound(s) 









Jeringau Rhizomes Essential 
oil 
























Lidah buaya Leaves Ethanol 
extract 























Coumarin In vitro, MIC 
125 µg/ mL 
27 
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Azadirachta 
indica/ Meliaceae 




























Seledri Herbs Ethanol 
extract 
























Kaki kuda Leaves Ethanol 
extract 






Kayu manis Steam 
barks 
Decoction  In vitro, MIC 




Jeruk Nipis Peels Essential 
oils 







Temu ireng Rhizomes Essential 
oils 
 In vitro, MIC 
100% 
37 









heyneana Val & 
Zijp/ 
Zingiberaceae 





Kunyit Rhizomes Fresh 
rhizomes 


































Pacar air Leaves Ethanol 
extract 
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Rambutan Stem barks Ethanol 
extract 














In vitro, MIC 
1024 µg/ mL 
52 
























L./  Piperaceae 















Pav./  Piperaceae 
Sirih merah Leaves Ethanol 
extract 





Kemboja Stem barks Ethyl 
acetate 
extract 
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In vitro, MIC 




Merr. & Perry/ 
Myrtaceae 
Cengkeh Leaves Essential 
oils 




  Clove oil Essential 
oils 
Eugenol In vitro, MIC 
0.64  µg/ mL, 
MCF 0.64-





Jahe Rhizomes Fresh 
rhizomes 




   Hydroalcoh
olic 
extracts 
 In vivo, 10 
mg/kg 
63 
MIC: minimal inhibitory concentration; MFC: minimal fungicidal concentration 
 
A total of 34 different Indonesian medicinal plants belonging to the 25 families were reported for anti-
Candida activity. Antifungal activity such as anti-Candida of extracts and compound is currently 
characterized in vitro by MIC and MFC. According Kuete and Efferth (2010)64, the potency extracts of 
medicinal plant as antifungal, based on their MIC values, can be categorized: (1) significant (MIC < 100 
µg/ mL or 0.01% w/v); (2) moderate (100<MIC≤625 µg/ mL or 0.01<MIC≤0.0625% w/v); and (3) weak 
(MIC > 625 µg/ mL or 0.0625% w/v). Therefore, the activity recorded with the 34 Indonesian medicinal 
plants reviewed could be considered as important for 2 (5.88%) and weak for 32 (94.12%). The plants 
which exhibited significant anti-Candida activity were: Curcuma xanthorrhiza and Syzygium aromaticum. 
These plants inhibit C. albicans through secondary metabolites such as xanthorrhizol for C. xanthorrhiza 
and eugenol for S. aromaticum.  
 
Anti-Candida mechanism of action of Indonesian medicinal plants 
Anti-Candida or antifungal mechanism of action of secondary metabolite reviewed Indonesian medicinal 
plants are presented in Table-2. In the present review, mechanism action of antifungal activities against C. 
albicans were exhibited by metabolites of ten Indonesian medicinal plants, namely, allicin from A. sativum, 
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diterpene from A. galanga, coumarin from A. canyzoides, terpenoids from C. limon, curcumin from C. 
longa, xanthorrhizol from C. xanthorrhiza, thymol from N. sativa, essential oils from O. sanctum, eugenol 
from S. aromaticum, and [6]-shogaol from Z. officinale. The metabolites of Indonesian medicinal plants 
have their antifungal mechanism well described in the literature: disruption of hyphae production by 
allicin65, filament and biofilm formation by [6]-shogaol66, curcumin67 and xanthorrhizol68, 69, envelope by 
eugenol70, membrane permeabilization by essential oils71, thymol72 and diterpene73, and cell wall by 
terpenoids36, thymol74, and coumarin27.  Metabolite from Indonesian medicinal plants mostly exerts their 
antifungal effects by growth inhibition, membrane, and cell wall active mechanism. This review indicated 
that needed to isolation and characterization of the bioactive compounds from Indonesian medicinal plants 
that responsible for anti-Candida activity in further studies. 
 
Table-2: Anti-Candida or antifungal mechanism of action of reviewed Indonesian medicinal plants 
 








Allicin C. albicans fitness 
test 
Inhibition SIR2 gene-related 
suppress hyphae production 
65 
Alpinia galanga (L) 
Willd./  
Diterpene C. albicans fitness 
test 




Coumarin C. albicans fitness 
test 
Damages cell by pore 




Terpenoids C. albicans fitness 
test 
Inhibition ergosterol synthesis 
(a component of cell wall) 
36 
Curcuma longa L./ 
Zingiberaceae 
Curcumin C. albicans fitness 
test 
Prevents induction of 
transcription of genes 
integrally involved in the 
processes related to biofilm 
formation by elicits anti-















Thymol C. albicans fitness 
test; Testing with 
sorbitol and 
ergosterol 
Involves a direct interaction 
with the cell wall structure or 








and 1, 8-cineole, 
Proton efflux 
measurements 
Inhibition of H+ extrusion by 




Merr. & Perry/ 
Myrtaceae 
Eugenol C. albicans fitness 
test 





[6]-Shogaol C. albicans fitness 
test 
Inhibition filament formation 66 
 
CONCLUSION 
In summary, the results of the present review indicated that 34 Indonesian medicinal plants belonging to 25 
families have been reported as being employed for anti-Candida. Ten plants have been explored for 
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metabolite and mechanism of mode action against pathogenic C. albicans. These results contribute to the 
drug discovering of the anti-Candida from Indonesian medicinal plants. There is a need for the isolation 
and characterization of the metabolite from Indonesian medicinal plants that responsible for the anti-
Candida properties.  
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